Home > Insider Trading > Filing (0001209191-15-009435)

Filing Details

Accession Number:: 0001209191-15-009435
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-04 16:42:07
Reporting Period:: 2015-02-02

Filing Date:: 2015-02-04
Accepted Time:: 2015-02-04 16:42:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
913165	Exactech Inc	EXAC	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	592603930

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1206758	A Betty Petty	6717 Nw 48Th Lane Gainesville FL 32653	Vice President, Administration	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-02	4,500	$14.12	74,900	No	4	M	Direct
Common Stock	Disposition	2015-02-02	4,500	$20.76	70,400	No	4	S	Direct
Common Stock	Acquisiton	2015-02-02	3,000	$13.40	102,400	No	4	M	Indirect	by Spouse
Common Stock	Disposition	2015-02-02	3,000	$20.72	99,400	No	4	S	Indirect	by Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Indirect	by Spouse
No	4	S	Indirect	by Spouse

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-02-02	4,500	$14.12	30,000	$14.12
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-02-02	3,000	$13.40	20,000	$13.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,500	2005-11-30	2015-05-09	No	4	M	Direct
9,000	2005-11-30	2015-05-31	No	4	M	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,146,338	Indirect	by Partnership

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-Qualified Stock Option (right to buy)	$14.27	2011-12-18	2016-12-18	5,000	5,000	Direct
Common Stock	Non-Qualified Option (right to buy)	$17.02	2013-02-16	2016-02-16	11,000	11,000	Direct
Common Stock	Non-Qualified Option (right to buy)	$18.95	2014-02-28	2017-02-28	2,800	2,800	Direct
Common Stock	Non-Qualified Option (right to buy)	$16.33	2017-02-22	2019-02-22	11,900	11,900	Direct
Common Stock	Non-Qualified Option (right to buy)	$18.55	2018-02-25	2020-02-25	3,000	3,000	Direct
Common Stock	Non-Qualified Option (right to buy)	$20.90	2019-05-09	2021-05-09	8,000	8,000	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$14.27	2011-12-18	2016-12-18	5,000	5,000	Indirect
Common Stock	Non-Qualified Option (right to buy)	$17.02	2013-02-16	2016-02-16	68,000	68,000	Indirect
Common Stock	Non-Qualified Option (right to buy)	$18.10	2012-02-22	2016-02-22	65,421	65,421	Indirect
Common Stock	Non-Qualified Option (right to buy)	$18.95	2014-02-28	2017-02-28	17,200	17,200	Indirect
Common Stock	Non-Qualified Option (right to buy)	$16.33	2017-02-22	2019-02-22	75,000	75,000	Indirect
Common Stock	Non-Qualified Option (right to buy)	$18.55	2018-02-25	2020-02-25	75,000	75,000	Indirect
Common Stock	Non-Qualified Option (right to buy)	$20.90	2019-05-09	2021-05-09	55,217	55,217	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-12-18	5,000	5,000	Direct
2016-02-16	11,000	11,000	Direct
2017-02-28	2,800	2,800	Direct
2019-02-22	11,900	11,900	Direct
2020-02-25	3,000	3,000	Direct
2021-05-09	8,000	8,000	Direct
2016-12-18	5,000	5,000	Indirect
2016-02-16	68,000	68,000	Indirect
2016-02-22	65,421	65,421	Indirect
2017-02-28	17,200	17,200	Indirect
2019-02-22	75,000	75,000	Indirect
2020-02-25	75,000	75,000	Indirect
2021-05-09	55,217	55,217	Indirect

Footnotes

Such in-the-money options were exercised by the Reporting Person in lieu of allowing such options to expire by their terms on May 9, 2015 pursuant to a Rule 10b5-1 plan to exercise and sell the underlying common shares beginning on January 2, 2015 and expiring May 8,2015.
Such in-the-money options were exercised by the Reporting Person in lieu of allowing such options to expire by their terms on May 31, 2015 pursuant to a Rule 10b5-1 plan to exercise and sell the underlying common shares beginning on January 2, 2015 and expiring May 29,2015.
Such options are currently exercisable as regards 4,760 of the covered shares. The remaining shares are exercisable, as regards 2,380 of the covered shares, on the third anniversary of the date of grant, as regards 2,380 of the covered shares on the fourth anniversary of the date of grant, and as regards 2,380 of the covered shares, on the fifth anniversary of the date of grant.
Such options are currently exercisable as regards 600 of the covered shares. The remaining shares are exercisable, as regards 600 of the covered shares, on the second anniversary of the date of grant, as regards 600 of the covered shares, on the third anniversary of the date of grant, as regards 600 of the covered shares on the fourth anniversary of the date of grant, and as regards 600 of the covered shares, on the fifth anniversary of the date of grant.
Such options are exercisable as regards 1,600 of the covered shares, on the first anniversary of the date of grant, as regards 1,600 of the covered shares, on the second anniversary of the date of grant, as regards 1,600 of the covered shares, on the third anniversary of the date of grant, as regards 1,600 of the covered shares on the fourth anniversary of the date of grant, and as regards 1,600 of the covered shares, on the fifth anniversary of the date of grant.
Such options were granted to Mrs. Petty's spouse, Dr. William Petty, Executive Chairman of the Board, of the Issuer.
Such options are currently exercisable as regards 30,000 of the covered shares. The remaining shares are exercisable, as regards 15,000 of the covered shares, on the third anniversary of the date of grant, as regards 15,000 of the covered shares on the fourth anniversary of the date of grant, and as regards 15,000 of the covered shares, on the fifth anniversary of the date of grant.
Such options are currently exercisable as regards 15,000 of the covered shares. The remaining shares are exercisable, as regards 15,000 of the covered shares, on the second anniversary of the date of grant, as regards 15,000 of the covered shares, on the third anniversary of the date of grant, as regards 15,000 of the covered shares on the fourth anniversary of the date of grant, and as regards 15,000 of the covered shares, on the fifth anniversary of the date of grant.
Such options are exercisable as regards 11,043 of the covered shares, on the first anniversary of the date of grant, as regards 11,043 of the covered shares, on the second anniversary of the date of grant, as regards 11,043 of the covered shares, on the third anniversary of the date of grant, as regards 11,044 of the covered shares on the fourth anniversary of the date of grant, and as regards 11,044 of the covered shares, on the fifth anniversary of the date of grant.